117 related articles for article (PubMed ID: 11364452)
1. Nelfinavir (Viracept) moves up the ranks.
Grodeck B
Posit Aware; 1997; 8(2):16-7. PubMed ID: 11364452
[TBL] [Abstract][Full Text] [Related]
2. New drug approved to treat HIV.
Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
[TBL] [Abstract][Full Text] [Related]
3. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
James JS
AIDS Treat News; 1997 Mar; (No 267):1-2. PubMed ID: 11364249
[TBL] [Abstract][Full Text] [Related]
4. Nelfinavir - major trial results at retroviruses conference.
AIDS Treat News; 1997 Feb; (No 265):3-4. PubMed ID: 11364240
[TBL] [Abstract][Full Text] [Related]
5. Nelfinavir: fourth protease inhibitor approved.
Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
[TBL] [Abstract][Full Text] [Related]
6. FDA approves nelfinavir. Food and Drug Administration.
GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
[TBL] [Abstract][Full Text] [Related]
7. Phase II/III Trials of Viracept start.
AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361632
[No Abstract] [Full Text] [Related]
8. Nelfinavir (Viracept).
Baker R; Bowers M
BETA; 1997 Mar; ():5. PubMed ID: 11364528
[TBL] [Abstract][Full Text] [Related]
9. Nelfinavir at six months.
PI Perspect; 1997 Mar; (No 21):11-2. PubMed ID: 11364207
[TBL] [Abstract][Full Text] [Related]
10. Nelfinavir combination therapy: ten-month report.
AIDS Treat News; 1997 Apr; (No 269):3. PubMed ID: 11364253
[TBL] [Abstract][Full Text] [Related]
11. Fourth protease inhibitor hits the market.
AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224
[TBL] [Abstract][Full Text] [Related]
12. Newly approved PI provides treatment options.
AIDS Alert; 1997 Jun; 12(6):68-9. PubMed ID: 11364360
[TBL] [Abstract][Full Text] [Related]
13. Nelfinavir is number 4 -- but should it bat cleanup, or lead off?
Mascolini M
J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):17-21. PubMed ID: 11364427
[TBL] [Abstract][Full Text] [Related]
14. Pediatric treatments.
AIDS Policy Law; 1997 Apr; 12(6):12. PubMed ID: 11364179
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
16. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
17. New formulation of saquinavir (Fortovase) is more effective.
Tam CW
Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
[TBL] [Abstract][Full Text] [Related]
18. Protease inhibitors at a glance...
Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198
[TBL] [Abstract][Full Text] [Related]
19. Protease inhibitor trials moving to next phase.
AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675
[TBL] [Abstract][Full Text] [Related]
20. Agouron protease inhibitor.
AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]